Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO
November 14, 2020 at 12:22 PM EST
RemeGen completed a $515 million IPO on the Hong Kong exchange in the largest biotech IPO of the year. The company's shares have traded 34% higher since the IPO, giving RemeGen a market capitalization of $4.3 billion.